# Closed-loop in Adults With Type 2 Diabetes

Study · id `cardio:ct-nct06579404` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06579404](<https://clinicaltrials.gov/study/NCT06579404>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06579404

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 224 participants.

## Technical summary

Registry record NCT06579404. Randomized; no masking; primary purpose treatment. Start 2024-12-06 (actual); primary completion 2027-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 224 participants (planned count; ClinicalTrials.gov record NCT06579404, source copy `cardio:ctgov-nct06579404-2026-03-13`, retrieved 2026-10-26)
- Started: 2024-12-06 (actual) (ClinicalTrials.gov record NCT06579404, source copy `cardio:ctgov-nct06579404-2026-03-13`, retrieved 2026-10-26)
- Primary completion: 2027-03 (anticipated) (ClinicalTrials.gov record NCT06579404, source copy `cardio:ctgov-nct06579404-2026-03-13`, retrieved 2026-10-26)
- Completion: 2027-07 (anticipated) (ClinicalTrials.gov record NCT06579404, source copy `cardio:ctgov-nct06579404-2026-03-13`, retrieved 2026-10-26)
- Countries: Australia; Austria; Czechia; France; Switzerland; United Kingdom (ClinicalTrials.gov record NCT06579404, source copy `cardio:ctgov-nct06579404-2026-03-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06579404-2026-03-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: Closed-loop in Adults With Type 2 Diabetes
- Acronym: COYOTE
- Condition: Type 2 Diabetes Treated With Insulin
- Intervention (Device): CamAPS HX
- Intervention (Other): Standard insulin therapy with glucose sensor
- Lead sponsor: University of Cambridge
- Lead sponsor class: OTHER
- Collaborator: University of Edinburgh
- Collaborator class: OTHER
- Collaborator: Jaeb Center for Health Research
- Collaborator class: OTHER
- Collaborator: Swansea University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: University of Cambridge (`cardio:org-university-of-cambridge`)
- Registry lists this organization as a collaborator: University of Edinburgh (`cardio:org-university-of-edinburgh`)
- Registry lists this organization as a collaborator: Jaeb Center for Health Research (`cardio:org-jaeb-center-for-health-research`)

## Provenance

Content hash: 663ae7d117d86ede9daccc0901e8a39f43443b22b42e5302b2bd12a7b0f92ed4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
